Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280496889> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W4280496889 endingPage "862" @default.
- W4280496889 startingPage "854" @default.
- W4280496889 abstract "Background: Cancer is a serious threaten to human life, and drug developers are pushing hard to discover potent anticancer agents. Pyrimidine and flavonoids are both attractive entities in medicinal chemistry; it is necessary to get new cancer drugs capitalizing on the two frameworks. Objective: This work includes the synthesis of series chrysin derivatives containing different substituted pyrimidines and an evaluation of their in vitro anticancer activity. Methods: Chrysin was merged with different substituted pyrimidines. Their antiproliferative activity was screened against five cancer cell lines (A549, HepG2, HCT116, MCF-7, and PC-3) using MTS method, and the marketed anticancer drug erlotinib was used as a reference. Results: Seventeen chrysin derivatives were synthesized. Compound 33E showed the best activity against A549, HepG2, MCF-7, and PC-3 cells, with IC50 values of 30.30 μM, 21.02 μM, 24.67 μM, 22.13 μM in A549, HepG2, MCF-7, PC-3 cells, respectively. Compound 33A showed the best activity against HCT116 cells, with an IC50 value of 4.83 μM in HCT116 cell lines. Conclusion: In the present study, a new set of chrysin derivatives containing anilinopyrimidine, piperazine- pyrimidine and piperidine-pyrimidine were prepared. Two compounds (33D, 33E) display higher toxicity than erlotinib toward the five cancerous cell lines (A549, HepG2, HCT116, MCF-7, and PC-3), and one compound (33A) exhibits better inhibitory activity than erlotinib to the HCT116 cells. These results underline the significance of the" @default.
- W4280496889 created "2022-05-22" @default.
- W4280496889 creator A5035402733 @default.
- W4280496889 creator A5035866587 @default.
- W4280496889 creator A5080376625 @default.
- W4280496889 date "2023-07-01" @default.
- W4280496889 modified "2023-09-27" @default.
- W4280496889 title "Design, Synthesis, and In vitro Anticancer Activity of Novel Chrysin Derivatives" @default.
- W4280496889 cites W1598763460 @default.
- W4280496889 cites W2000154460 @default.
- W4280496889 cites W2035263516 @default.
- W4280496889 cites W2164460325 @default.
- W4280496889 cites W2318882207 @default.
- W4280496889 cites W2345320779 @default.
- W4280496889 cites W2761052490 @default.
- W4280496889 cites W3049081975 @default.
- W4280496889 cites W3164056006 @default.
- W4280496889 doi "https://doi.org/10.2174/1570180819666220512150604" @default.
- W4280496889 hasPublicationYear "2023" @default.
- W4280496889 type Work @default.
- W4280496889 citedByCount "0" @default.
- W4280496889 crossrefType "journal-article" @default.
- W4280496889 hasAuthorship W4280496889A5035402733 @default.
- W4280496889 hasAuthorship W4280496889A5035866587 @default.
- W4280496889 hasAuthorship W4280496889A5080376625 @default.
- W4280496889 hasConcept C121608353 @default.
- W4280496889 hasConcept C126322002 @default.
- W4280496889 hasConcept C170493617 @default.
- W4280496889 hasConcept C185592680 @default.
- W4280496889 hasConcept C202751555 @default.
- W4280496889 hasConcept C2777752497 @default.
- W4280496889 hasConcept C2778004101 @default.
- W4280496889 hasConcept C2778087573 @default.
- W4280496889 hasConcept C2779054382 @default.
- W4280496889 hasConcept C2779321679 @default.
- W4280496889 hasConcept C2779438470 @default.
- W4280496889 hasConcept C2779478871 @default.
- W4280496889 hasConcept C2780035454 @default.
- W4280496889 hasConcept C54355233 @default.
- W4280496889 hasConcept C55493867 @default.
- W4280496889 hasConcept C71240020 @default.
- W4280496889 hasConcept C71924100 @default.
- W4280496889 hasConcept C81729549 @default.
- W4280496889 hasConcept C81885089 @default.
- W4280496889 hasConcept C86803240 @default.
- W4280496889 hasConcept C96232424 @default.
- W4280496889 hasConcept C98274493 @default.
- W4280496889 hasConceptScore W4280496889C121608353 @default.
- W4280496889 hasConceptScore W4280496889C126322002 @default.
- W4280496889 hasConceptScore W4280496889C170493617 @default.
- W4280496889 hasConceptScore W4280496889C185592680 @default.
- W4280496889 hasConceptScore W4280496889C202751555 @default.
- W4280496889 hasConceptScore W4280496889C2777752497 @default.
- W4280496889 hasConceptScore W4280496889C2778004101 @default.
- W4280496889 hasConceptScore W4280496889C2778087573 @default.
- W4280496889 hasConceptScore W4280496889C2779054382 @default.
- W4280496889 hasConceptScore W4280496889C2779321679 @default.
- W4280496889 hasConceptScore W4280496889C2779438470 @default.
- W4280496889 hasConceptScore W4280496889C2779478871 @default.
- W4280496889 hasConceptScore W4280496889C2780035454 @default.
- W4280496889 hasConceptScore W4280496889C54355233 @default.
- W4280496889 hasConceptScore W4280496889C55493867 @default.
- W4280496889 hasConceptScore W4280496889C71240020 @default.
- W4280496889 hasConceptScore W4280496889C71924100 @default.
- W4280496889 hasConceptScore W4280496889C81729549 @default.
- W4280496889 hasConceptScore W4280496889C81885089 @default.
- W4280496889 hasConceptScore W4280496889C86803240 @default.
- W4280496889 hasConceptScore W4280496889C96232424 @default.
- W4280496889 hasConceptScore W4280496889C98274493 @default.
- W4280496889 hasFunder F4320322665 @default.
- W4280496889 hasFunder F4320325626 @default.
- W4280496889 hasIssue "7" @default.
- W4280496889 hasLocation W42804968891 @default.
- W4280496889 hasOpenAccess W4280496889 @default.
- W4280496889 hasPrimaryLocation W42804968891 @default.
- W4280496889 hasRelatedWork W1726805491 @default.
- W4280496889 hasRelatedWork W2000602679 @default.
- W4280496889 hasRelatedWork W2003452985 @default.
- W4280496889 hasRelatedWork W2372999700 @default.
- W4280496889 hasRelatedWork W2753780674 @default.
- W4280496889 hasRelatedWork W3002443851 @default.
- W4280496889 hasRelatedWork W3029012193 @default.
- W4280496889 hasRelatedWork W4280496889 @default.
- W4280496889 hasRelatedWork W4286268598 @default.
- W4280496889 hasRelatedWork W4381194625 @default.
- W4280496889 hasVolume "20" @default.
- W4280496889 isParatext "false" @default.
- W4280496889 isRetracted "false" @default.
- W4280496889 workType "article" @default.